It is worth proposing that AHNAK2 was significantly associated with all four indicators including OS, PFS, DFS and DSS in lung adenocarcinoma patients, which is also consistent with our previous findings (50). This evidence concerns the gene AHNAK2 and lung adenocarcinoma.